Volume 29, Number 5—May 2023
Research
Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–20201
Table 2
SOC CDI test results | No. study primary CDI cases | No. not study primary CDI cases | Total |
---|---|---|---|
SOC primary CDI cases | 63 | 12 | 75 |
SOC C. difficile carriage | 13 | 17 | 30 |
Not SOC primary CDI cases |
3 |
30 |
33 |
Total |
79 |
59 |
138 |
*CDI, Clostridioides difficile infection; SOC, standard-of-care. |
1Study results were presented at the annual Anaerobe 2022 Congress, July 28–31, 2022, Seattle, Washington, USA.
2Current affiliation: Norton Healthcare, Louisville, Kentucky, USA.
3Current affiliation: AstraZeneca Pharmaceuticals, Wilmington, Delaware, USA.
Page created: March 10, 2023
Page updated: April 18, 2023
Page reviewed: April 18, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.